Achieve Life Sciences (ACHV) Depreciation & Amortization (CF) (2016 - 2026)
Achieve Life Sciences (ACHV) has disclosed Depreciation & Amortization (CF) for 17 consecutive years, with $57000.0 as the latest value for Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 8.06% to $57000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $223000.0 through Mar 2026, down 4.7% year-over-year, with the annual reading at $228000.0 for FY2025, 0.44% changed from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 was $57000.0 at Achieve Life Sciences, roughly flat from $57000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $65000.0 in Q4 2022, with the low at $54000.0 in Q3 2025.
- Average Depreciation & Amortization (CF) over 5 years is $57529.4, with a median of $57000.0 recorded in 2023.
- The sharpest move saw Depreciation & Amortization (CF) dropped 12.31% in 2023, then rose 8.77% in 2025.
- Achieve Life Sciences' Depreciation & Amortization (CF) stood at $65000.0 in 2022, then dropped by 12.31% to $57000.0 in 2023, then increased by 1.75% to $58000.0 in 2024, then decreased by 1.72% to $57000.0 in 2025, then changed by 0.0% to $57000.0 in 2026.
- Per Business Quant, the three most recent readings for ACHV's Depreciation & Amortization (CF) are $57000.0 (Q1 2026), $57000.0 (Q4 2025), and $54000.0 (Q3 2025).